Delivery Order SPE2DR25D7056-SPE2DR26FV8MX
Award Date 11/14/25
Potential Completion Date 11/17/25
Potential Value $5.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,444.77 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity). This firm fixed price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of October 29, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Procainamide 1,000 mg/2 mL vials with a contract value of $6,203.12 and an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat abnormal heart rhythms and is a critical pharmaceutical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for procurement of Procainamide 1 gram/10 milliliter vials with a ceiling value of $5,235.21. This firm fixed price delivery order was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and represents a non-competitive award. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Department's Medical Supply Chain for one gram per 10 milliliter vials of Procainamide, a cardiac antiarrhythmic medication. The May 30, 2025 award, valued at $1,562.92 with completion scheduled for June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,968.88 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract covers the supply of Procainamide 1 gram/10 milliliter vials (10 milliliter quantity), an antiarrhythmic medication used in cardiac care. This is a firm fixed-price delivery order with no set-aside designation, awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $6,171.16 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/10 mL vials (10 mL quantity) on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed out of the contractor's Conshohocken, Pennsylvania facility. The award is issued as a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.11 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on August 27, 2025. This firm fixed price delivery order, with an ultimate completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $1,291.09 delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 4, 2025, with completion targeted for November 5, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions, reflecting open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Procainamide 1 gram/10 milliliter vials with a ceiling value of $2,137.63. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...